UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities

International journal of antimicrobial agents, 2014-01, Vol.43 (1), p.78-81

2014

Volltextzugriff (PDF)

Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates

PloS one, 2016-04, Vol.11 (4), p.e0153014-e0153014

2016

Volltextzugriff (PDF)

A global view on carbapenem-resistant Acinetobacter baumannii

mBio, 2023-12, Vol.14 (6), p.e0226023

2023

Volltextzugriff (PDF)

Nosocomial bloodstream infections due to Acinetobacter baumannii , Acinetobacter pittii and Acinetobacter nosocomialis in the United States

The Journal of infection, 2012-03, Vol.64 (3), p.282-290

2012

Volltextzugriff (PDF)

Standardization and Interlaboratory Reproducibility Assessment of Pulsed-Field Gel Electrophoresis-Generated Fingerprints of Acinetobacter baumannii

Journal of Clinical Microbiology, 2005-09, Vol.43 (9), p.4328-4335

2005

Volltextzugriff (PDF)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates

Antibiotics (Basel), 2023-07, Vol.12 (7), p.1172

2023

Volltextzugriff (PDF)

In Vitro Activities of the β-Lactamase Inhibitors Clavulanic Acid, Sulbactam, and Tazobactam Alone or in Combination with β-Lactams against Epidemiologically Characterized Multidrug-Resistant Acinetobacter baumannii Strains

Antimicrobial Agents and Chemotherapy, 2004-05, Vol.48 (5), p.1586-1592

2004

Volltextzugriff (PDF)

Evaluation of Quantitative Antibiotic Susceptibility Testing by Vitek 2 as a Routine Method To Predict Strain Relatedness of Coagulase-Negative Staphylococci Isolated from Blood Cultures

Journal of Clinical Microbiology, 2011-09, Vol.49 (9), p.3355-3357

2011

Volltextzugriff (PDF)

Bloodstream Infection in Neutropenic Cancer Patients Related to Short-Term Nontunnelled Catheters Determined by Quantitative Blood Cultures, Differential Time to Positivity, and Molecular Epidemiological Typing with Pulsed-Field Gel Electrophoresis

Journal of Clinical Microbiology, 2003-01, Vol.41 (1), p.118-123

2003

Volltextzugriff (PDF)

In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii

International journal of antimicrobial agents, 2018-01, Vol.51 (1), p.62-64

2018

Volltextzugriff (PDF)

In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii

Journal of antimicrobial chemotherapy, 2020-09, Vol.75 (9), p.2616-2621

2020

Volltextzugriff (PDF)

Molecular Evolution of Methicillin-Resistant Staphylococcus aureus in the Metropolitan Area of Cologne, Germany, from 1984 to 1998

Journal of Clinical Microbiology, 2005-11, Vol.43 (11), p.5445-5451

2005

Volltextzugriff (PDF)

In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii

International journal of antimicrobial agents, 2020-01, Vol.55 (1), p.105829-105829, Article 105829

2020

Volltextzugriff (PDF)

The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem‐resistant Acinetobacter baumannii isolates in Germany, 2010‐2019

International journal of antimicrobial agents, 2022-11, Vol.60 (5-6), p.106689-106689, Article 106689

2022

Volltextzugriff (PDF)

Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo

Antimicrobial agents and chemotherapy, 2019-03, Vol.63 (3)

2019

Volltextzugriff (PDF)

Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii

International journal of antimicrobial agents, 2020-03, Vol.55 (3), p.105862-105862, Article 105862

2020

Volltextzugriff (PDF)

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant IAcinetobacter baumannii/I Isolates

Antibiotics (Basel), 2023-07, Vol.12 (7)

2023

Volltextzugriff (PDF)

BIOnic Liquids: Imidazolium-based Ionic Liquids with Antimicrobial Activity

Zeitschrift für Naturforschung. B, A journal of chemical sciences, 2013-10, Vol.68 (10), p.1123-1128

2013

Volltextzugriff (PDF)

In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates

International journal of antimicrobial agents, 2015-06, Vol.45 (6), p.641-646

2015

Volltextzugriff (PDF)

Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care

The Journal of infection, 2018-12, Vol.77 (6), p.516-525

2018

Volltextzugriff (PDF)

In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii

Journal of antimicrobial chemotherapy, 2012-05, Vol.67 (5), p.1167-1169

2012

Volltextzugriff (PDF)

Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates

Journal of antimicrobial chemotherapy, 2006-11, Vol.58 (5), p.1099-1100

2006

Volltextzugriff (PDF)

Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials

The Journal of infection, 2017-03, Vol.74 (3), p.248-259

2017

Volltextzugriff (PDF)

The susceptibility of Eravacycline and Comparators to Global Isolates of Acinetobacter baumannii

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii

Journal of antimicrobial chemotherapy, 2004-10, Vol.54 (4), p.821-823

2004

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities

Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates

A global view on carbapenem-resistant Acinetobacter baumannii

Nosocomial bloodstream infections due to Acinetobacter baumannii , Acinetobacter pittii and Acinetobacter nosocomialis in the United States

Standardization and Interlaboratory Reproducibility Assessment of Pulsed-Field Gel Electrophoresis-Generated Fingerprints of Acinetobacter baumannii

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates

In Vitro Activities of the β-Lactamase Inhibitors Clavulanic Acid, Sulbactam, and Tazobactam Alone or in Combination with β-Lactams against Epidemiologically Characterized Multidrug-Resistant Acinetobacter baumannii Strains

Evaluation of Quantitative Antibiotic Susceptibility Testing by Vitek 2 as a Routine Method To Predict Strain Relatedness of Coagulase-Negative Staphylococci Isolated from Blood Cultures

Bloodstream Infection in Neutropenic Cancer Patients Related to Short-Term Nontunnelled Catheters Determined by Quantitative Blood Cultures, Differential Time to Positivity, and Molecular Epidemiological Typing with Pulsed-Field Gel Electrophoresis

In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii

In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii

Molecular Evolution of Methicillin-Resistant Staphylococcus aureus in the Metropolitan Area of Cologne, Germany, from 1984 to 1998

In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii

The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem‐resistant Acinetobacter baumannii isolates in Germany, 2010‐2019

Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo

Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant IAcinetobacter baumannii/I Isolates

BIOnic Liquids: Imidazolium-based Ionic Liquids with Antimicrobial Activity

In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates

Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care

In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii

Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates

Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials

The susceptibility of Eravacycline and Comparators to Global Isolates of Acinetobacter baumannii

Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii

Suchergebnisse filtern